2021-06-09 16:21:18
A small study looking at 30 patients aged six to 17 years old randomized these children into groups receiving beclomethasone (250 ug BID) for asthma treatment. One group also received a probiotic containing Lactobacillus reuteri (10^8 colony-forming units (CFU)). After 60 days of treatment, the patients were reassessed with the Asthma Control test, spirometry and self-reported symptoms associated with asthma. The study found that compared to beclomethasone alone, the addition of the probiotics resulted in improved Asthma Control Test scores, and a reduction symptom expression. These results show promise in the inclusion of probiotics in the supplemental treatment of children/adolescents with asthma.
[collapse collapsed title=Reference] Moura, J. C. V., Moura, I. C. G., Gaspar, G. R., Mendes, G. M. S., Faria, B. A. V., Jentzsch, N. S., … & Almeida, A. M. (2019). The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications. Clinics, 74.